JACQUELINE MAHADY SMITH: Open Payments
NPI 1073529590 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 17 payments from 8 companies in 2025. Trend: 2023 $156 · 2024 $299 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $105 |
| GlaxoSmithKline, LLC. | 4 | $89 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $43 |
| Optinose US, Inc. | 2 | $33 |
| AERIN MEDICAL INC. | 1 | $33 |
| Medtronic, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Preceptis Medical, Inc. | 1 | $10 |
Products named: DUPIXENT, NUCALA, NEFFY, Xhance, VIVAER STYLUS, PROPEL, CAPLYTA.
Industry payments across NY — which companies pay providers there.
